Alpha Tau Medical Raises $28.2M in Direct Offering
Ticker: DRTSW · Form: 6-K · Filed: Apr 28, 2025 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: registered-direct-offering, capital-raise, share-purchase-agreement
TL;DR
Alpha Tau Medical sells 14.1M shares to Oramed for $28.2M in a direct offering.
AI Summary
On April 24, 2025, Alpha Tau Medical Ltd. entered into a share purchase agreement with Oramed Ltd. for a registered direct offering. The company will sell 14,110,121 ordinary shares at a purchase price of $2 per share, resulting in gross proceeds of approximately $28.2 million before deducting offering expenses.
Why It Matters
This capital infusion provides Alpha Tau Medical with funds to advance its cancer treatment technology, potentially impacting future clinical trials and commercialization efforts.
Risk Assessment
Risk Level: medium — The company is raising capital through a direct offering, which can dilute existing shareholders and may indicate a need for funding to advance its business operations.
Key Numbers
- $28.2M — Gross Proceeds (Raised from the registered direct offering.)
- 14,110,121 — Shares Sold (Number of ordinary shares sold in the offering.)
- $2 — Price Per Share (Purchase price for each ordinary share.)
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- Oramed Ltd. (company) — Investor
- April 24, 2025 (date) — Date of Purchase Agreement
- 14,110,121 (number) — Number of shares sold
- $2 (dollar_amount) — Purchase price per share
- $28.2 million (dollar_amount) — Gross proceeds from offering
FAQ
What is the purpose of the registered direct offering?
The filing does not explicitly state the purpose of the offering, but it is common for companies to raise capital for general corporate purposes, research and development, or to fund clinical trials.
Who is the investor in this registered direct offering?
The investor is Oramed Ltd.
How many shares is Alpha Tau Medical Ltd. selling?
Alpha Tau Medical Ltd. is selling 14,110,121 ordinary shares.
At what price are the shares being sold?
The shares are being sold at a purchase price of $2 per share.
What are the expected gross proceeds from this offering?
The expected gross proceeds are approximately $28.2 million (14,110,121 shares * $2/share).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 28, 2025 regarding Alpha Tau Medical Ltd. (DRTSW).